Study investigates the sustainability in blood pressure reduction through a 12-month lifestyle intervention

FHS
June 21, 2023
6:02 pm

The sustainability and scalability of limited duration interventions in low- and middle-income countries remain unclear.

Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m – Pharmaceutical Technology

CRISPR/Cas9 is a gene-editing technology that allows scientists to precisely cut and modify DNA in living organisms. Credit: Prostock-studio via Shutterstock. Amidst the long-running Cas9

October 6, 2024

Rad AI Scores $50M to Empower Radiologists with Generative AI

Rad AI What You Should Know: – Rad AI, a leader in generative AI for healthcare, announced today it has raised $50M in Series B

May 8, 2024

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

Switching vitamin K antagonist (VKA) treatment to a non-vitamin K antagonist oral anticoagulant (NOAC) in frail elderly patients with atrial fibrillation is associated with more

August 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.